MAY 10, 2021 7:15 AM PDT

Getting RNA-Based Medicine Past the Blood-Brain Barrier

WRITTEN BY: Carmen Leitch

RNA molecules serve several functions, one of which is to help the cell generate proteins from active genes. It also may be possible to treat many diseases by targeting RNA molecules with a system called siRNA (small interfering RNA). These molecules are typically easy to manufacture and have recently been shown to act on biochemical pathways that have previously been elusive.  But sometimes it's difficult to get RNA-targeting drugs where they need to go to have an impact, like into the brain.

Georgia Tech Mechanical Engineering Ph.D. student Yutong Guo (left) and her mentor, assistant professor Costas Arvanitis, have developed a way to use ultrasonics to treat brain disease. / Credi:  Ashley Ritchey, Georgia Tech

Though the brain is protected by a barrier, researchers have now created a way to deliver siRNA molecules there. The work, which was reported in Science Advances, uses ultrasound and nanoparticles packed with siRNA molecules to get by the blood-brain barrier and target brain tumors with medicine.

"We're able to make this drug more available to the brain and we're seeing a substantial increase in tumor cell death, which is huge," said corresponding study author Costas Arvanitis, assistant professor at Georgia Tech's George W. Woodruff School of Mechanical Engineering (ME). "Our results were very positive, but if you think I'm excited, you haven't talked to oncologists - they're ten times as excited," Arvanitis said.

RNA-based molecules don't usually stick around in the body for a long time, which can be good, but also means that cells won't have access to RNA-based drugs for long before they're degraded or otherwise lost. Cells may also not take them up efficiently. To improve delivery and make them last longer, scientists have created nanoscale carriers to move them around. But these nanocarriers are too big to move through the blood-brain barrier.

Arvanitis and collaborators have now modified the ultrasound and combined it with microbubbles, tiny bits of gases in the bloodstream that vibrate in response to ultrasound waves. They tested it with a mouse model.

"Focusing multiple beams of ultrasound energy onto a cancerous spot caused the microbubbles' vibrations to actually stretch, pull, or shear the tight junctions of endothelial tissue that make up the blood-brain barrier, creating an opening for drugs to get through," explained ME grad student Yutong Guo.

The nanocarriers contain siRNA, which is able to bind to active mRNA molecules to stop them from expressing proteins. The idea is to halt the expression of genes that promote cancer formation. The approach worked in mouse models of preclinical and pediatric brain cancer. Single-cell analysis indicated that harmful protein levels were reduced and tumor cells were dying.

This tool has been in development for years, and recently, clinical trials have shown that it's safe. This work might be the first to show that it can be used to deliver nanoparticles to brain tumor cells directly.

"This is completely tunable," Arvanitis said. "We can fine-tune the ultrasound pressure to attain a desired level of vibration and by extension drug delivery. It's non-invasive, because we are applying sound from outside the brain, and it's very localized because we can focus the ultrasound to a very small region of the brain."

Arvanitis noted that "this technology can provide treatment with minimal side effects, which is very exciting. Now we are moving forward to try and identify what components are missing to translate this technology to the clinic."

Sources: AAAS/Eurekalert! via Georgia Institute of Technology, Science Advances

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 14, 2021
Genetics & Genomics
RSV Infections Can Modify Host Immune Gene Activity
OCT 14, 2021
RSV Infections Can Modify Host Immune Gene Activity
Respiratory syncytial virus (RSV) are thought to be incredibly common; research has suggested that almost everyone is ev ...
OCT 15, 2021
Genetics & Genomics
Genes Seem to Significantly Impact the Results We Get From Exercise
OCT 15, 2021
Genes Seem to Significantly Impact the Results We Get From Exercise
Individual health is shaped by many different factors, including the sequences and expression levels of genes, the makeu ...
OCT 27, 2021
Cell & Molecular Biology
Lasers Stimulate Stem Cells to Grow & Specialize Faster
OCT 27, 2021
Lasers Stimulate Stem Cells to Grow & Specialize Faster
Our body can only repair so much damage or injury, so treatments that can regenerate damaged or dead tissues may be very ...
OCT 28, 2021
Cell & Molecular Biology
The Production & Export of Ribosomal Subunits is Caught on Video
OCT 28, 2021
The Production & Export of Ribosomal Subunits is Caught on Video
Protein production is essential for life; cells use DNA to transcribe active genes into RNA sequences, and ribosomes tra ...
NOV 01, 2021
Health & Medicine
How Our Understanding of Cellular Reprogramming May Redefine Transplant Medicine
NOV 01, 2021
How Our Understanding of Cellular Reprogramming May Redefine Transplant Medicine
Liver disease represents a significant public health concern and was diagnosed in roughly 4.5 million adults i ...
NOV 26, 2021
Cell & Molecular Biology
Twin Study Reveals Epigenetic Links to Type 2 Diabetes
NOV 26, 2021
Twin Study Reveals Epigenetic Links to Type 2 Diabetes
Identical twins carry the same genome in their cells, which makes them powerful subjects in the study of human disease. ...
Loading Comments...